Robert L. Nussbaum, Chief Medical Officer at Invitae Corp (NVTA), sold 59,566 shares at $33.38 ($2.0M) on 2020-07-09, disclosed to the SEC on 2020-07-13.
Open-market sale of $2.0M NVTA by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $33.38 | 5,986 | $200K | 9.8% |
| 2 | $33.38 | 5,986 | $200K | 9.8% |
| 3 | $34.31 | 22,347 | $767K | 37.7% |
| 4 | $34.31 | 22,347 | $767K | 37.7% |
| 5 | $34.93 | 1,450 | $51K | 2.5% |
| 6 | $34.93 | 1,450 |
| $51K |
| 2.5% |
| Total | $34.15 avg | 59,566 | $2.0M | 100% |
| Filing → |
| NVTA | SELL | 2023-03-15 | $4K | — | Filing → |
| NVTA | SELL | 2022-08-18 | $32K | — | Filing → |
| NVTA | SELL | 2022-05-19 | $23K | — | Filing → |